|
C2ORF15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.470600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.645200E-01 |
| Normal-vs-Stage2 |
1.794200E-01 |
| Normal-vs-Stage3 |
4.840400E-01 |
| Normal-vs-Stage4 |
1.964040E-01 |
| Stage1-vs-Stage2 |
8.747600E-02 |
| Stage1-vs-Stage3 |
4.880400E-01 |
| Stage1-vs-Stage4 |
1.544990E-01 |
| Stage2-vs-Stage3 |
5.070200E-02 |
| Stage2-vs-Stage4 |
1.763550E-02 |
| Stage3-vs-Stage4 |
5.353200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.768400E-01 |
| Normal-vs-AfricanAmerican |
7.279200E-01 |
| Normal-vs-Asian |
8.464000E-01 |
| Caucasian-vs-AfricanAmerican |
4.451400E-01 |
| Caucasian-vs-Asian |
6.236200E-01 |
| AfricanAmerican-vs-Asian |
6.120000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.846000E-01 |
| Normal-vs-Female |
7.472200E-01 |
| Male-vs-Female |
5.700200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.260400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.840600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.344200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.285800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.655600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.072620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.522200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.724600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.141700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.158400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.320600E-01 |
| Classical-VS-Follicular |
3.976100E-02 |
| Classical-VS-Other |
5.531400E-01 |
| Classical-VS-Normal |
7.197400E-01 |
| Tall-VS-Follicular |
9.114100E-02 |
| Tall-VS-Other |
4.635200E-01 |
| Tall-VS-Normal |
3.835000E-01 |
| Follicular-VS-Other |
8.195800E-01 |
| Follicular-VS-Normal |
1.521640E-01 |
| Other-VS-Normal |
7.680200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.002800E-01 |
| Normal-vs-N1 |
1.653970E-02 |
| N0-vs-N1 |
2.221400E-03 |
|
|
